Literature DB >> 24155395

Human cytomegalovirus infection of langerhans-type dendritic cells does not require the presence of the gH/gL/UL128-131A complex and is blocked after nuclear deposition of viral genomes in immature cells.

Elvin J Lauron1, Dong Yu, Anthony R Fehr, Laura Hertel.   

Abstract

Human cytomegalovirus (CMV) enters its host via the oral and genital mucosae. Langerhans-type dendritic cells (LC) are the most abundant innate immune cells at these sites, where they constitute a first line of defense against a variety of pathogens. We previously showed that immature LC (iLC) are remarkably resistant to CMV infection, while mature LC (mLC) are more permissive, particularly when exposed to clinical-strain-like strains of CMV, which display a pentameric complex consisting of the viral glycoproteins gH, gL, UL128, UL130, and UL131A on their envelope. This complex was recently shown to be required for the infection of immature monocyte-derived dendritic cells. We thus sought to establish if the presence of this complex is also necessary for virion penetration of LC and if defects in entry might be the source of iLC resistance to CMV. Here we report that the efficiency of LC infection is reduced, but not completely abolished, in the absence of the pentameric complex. While virion penetration and nuclear deposition of viral genomes are not impaired in iLC, the transcription of the viral immediate early genes UL122 and UL123 and of the delayed early gene UL50 is substantially lower than that in mLC. Together, these data show that the UL128, UL130, and UL131A proteins are dispensable for CMV entry into LC and that progression of the viral cycle in iLC is restricted at the step of viral gene expression.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24155395      PMCID: PMC3911714          DOI: 10.1128/JVI.03062-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  107 in total

Review 1.  Immunobiology of dendritic cells.

Authors:  J Banchereau; F Briere; C Caux; J Davoust; S Lebecque; Y J Liu; B Pulendran; K Palucka
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

Review 2.  Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity.

Authors:  Y J Liu
Journal:  Cell       Date:  2001-08-10       Impact factor: 41.582

3.  Construction of a self-excisable bacterial artificial chromosome containing the human cytomegalovirus genome and mutagenesis of the diploid TRL/IRL13 gene.

Authors:  Dong Yu; Gregory A Smith; Lynn W Enquist; Thomas Shenk
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

4.  Targeting the function of mature dendritic cells by human cytomegalovirus: a multilayered viral defense strategy.

Authors:  M J Raftery; M Schwab; S M Eibert; Y Samstag; H Walczak; G Schönrich
Journal:  Immunity       Date:  2001-12       Impact factor: 31.745

5.  Monocyte-derived dendritic cells are permissive to the complete replicative cycle of human cytomegalovirus.

Authors:  S Riegler; H Hebart; H Einsele; P Brossart; G Jahn; C Sinzger
Journal:  J Gen Virol       Date:  2000-02       Impact factor: 3.891

6.  Human cytomegalovirus US7, US8, US9, and US10 are cytoplasmic glycoproteins, not found at cell surfaces, and US9 does not mediate cell-to-cell spread.

Authors:  Mary T Huber; Roman Tomazin; Todd Wisner; Jessica Boname; David C Johnson
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

7.  Human cytomegalovirus inhibits maturation and impairs function of monocyte-derived dendritic cells.

Authors:  Magdalena Moutaftsi; Anja M Mehl; Leszek K Borysiewicz; Zsuzsanna Tabi
Journal:  Blood       Date:  2002-04-15       Impact factor: 22.113

8.  Tropism of human cytomegalovirus for endothelial cells is determined by a post-entry step dependent on efficient translocation to the nucleus.

Authors:  C Sinzger; M Kahl; K Laib; K Klingel; P Rieger; B Plachter; G Jahn
Journal:  J Gen Virol       Date:  2000-12       Impact factor: 3.891

9.  Human cytomegalovirus induces a direct inhibitory effect on antigen presentation by monocyte-derived immature dendritic cells.

Authors:  Ulrich Grigoleit; Susanne Riegler; Hermann Einsele; Kerstin Laib Sampaio; Gerhard Jahn; Holger Hebart; Peter Brossart; Friderike Frank; Christian Sinzger
Journal:  Br J Haematol       Date:  2002-10       Impact factor: 6.998

10.  Myeloid blood CD11c(+) dendritic cells and monocyte-derived dendritic cells differ in their ability to stimulate T lymphocytes.

Authors:  Yuko Osugi; Slavica Vuckovic; Derek N J Hart
Journal:  Blood       Date:  2002-10-15       Impact factor: 22.113

View more
  15 in total

1.  Cytomegalovirus Virions Shed in Urine Have a Reversible Block to Epithelial Cell Entry and Are Highly Resistant to Antibody Neutralization.

Authors:  Xiaohong Cui; Stuart P Adler; Mark R Schleiss; Ravit Arav-Boger; Gail J Demmler Harrison; Michael A McVoy
Journal:  Clin Vaccine Immunol       Date:  2017-06-05

Review 2.  Virion Glycoprotein-Mediated Immune Evasion by Human Cytomegalovirus: a Sticky Virus Makes a Slick Getaway.

Authors:  Thomas J Gardner; Domenico Tortorella
Journal:  Microbiol Mol Biol Rev       Date:  2016-06-15       Impact factor: 11.056

Review 3.  Principles for studying in vivo attenuation of virus mutants: defining the role of the cytomegalovirus gH/gL/gO complex as a paradigm.

Authors:  Jürgen Podlech; Matthias J Reddehase; Barbara Adler; Niels A W Lemmermann
Journal:  Med Microbiol Immunol       Date:  2015-03-18       Impact factor: 3.402

4.  Production of Cytomegalovirus Dense Bodies by Scalable Bioprocess Methods Maintains Immunogenicity and Improves Neutralizing Antibody Titers.

Authors:  Kirsten Schneider-Ohrum; Corinne Cayatte; Yi Liu; Zhaoti Wang; Alivelu Irrinki; Floro Cataniag; Nga Nguyen; Stacie Lambert; Hui Liu; Shahin Aslam; Greg Duke; Michael P McCarthy; Louise McCormick
Journal:  J Virol       Date:  2016-10-28       Impact factor: 5.103

5.  Dynamics of Human Cytomegalovirus Infection in CD34+ Hematopoietic Cells and Derived Langerhans-Type Dendritic Cells.

Authors:  Roxanne Coronel; Sachiko Takayama; Timothy Juwono; Laura Hertel
Journal:  J Virol       Date:  2015-03-11       Impact factor: 5.103

6.  A cytomegalovirus DNA vaccine induces antibodies that block viral entry into fibroblasts and epithelial cells.

Authors:  Michael A McVoy; Ronzo Lee; Frances M Saccoccio; Jukka Hartikka; Larry R Smith; Rohit Mahajan; Jian Ben Wang; Xiaohong Cui; Stuart P Adler
Journal:  Vaccine       Date:  2015-10-24       Impact factor: 3.641

Review 7.  Human cytomegalovirus tropism for mucosal myeloid dendritic cells.

Authors:  Laura Hertel
Journal:  Rev Med Virol       Date:  2014-06-02       Impact factor: 6.989

8.  The pentameric complex drives immunologically covert cell-cell transmission of wild-type human cytomegalovirus.

Authors:  Isa Murrell; Carmen Bedford; Kristin Ladell; Kelly L Miners; David A Price; Peter Tomasec; Gavin W G Wilkinson; Richard J Stanton
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-22       Impact factor: 12.779

9.  Human cytomegalovirus vaccine based on the envelope gH/gL pentamer complex.

Authors:  Felix Wussow; Flavia Chiuppesi; Joy Martinez; John Campo; Erica Johnson; Christin Flechsig; Maegan Newell; Elaine Tran; Jose Ortiz; Corinna La Rosa; Andreas Herrmann; Jeff Longmate; Rana Chakraborty; Peter A Barry; Don J Diamond
Journal:  PLoS Pathog       Date:  2014-11-20       Impact factor: 6.823

10.  Genetic Stability of Bacterial Artificial Chromosome-Derived Human Cytomegalovirus during Culture In Vitro.

Authors:  Isa Murrell; Gavin S Wilkie; Andrew J Davison; Evelina Statkute; Ceri A Fielding; Peter Tomasec; Gavin W G Wilkinson; Richard J Stanton
Journal:  J Virol       Date:  2016-03-28       Impact factor: 6.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.